3RS-(3R*,4S*,5R*)-2,3,5-TRIPHENYL-4-PIPERIDINYLOXOISOXAZOLIDINE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | LWJwZHZSyb5 |
|---|---|
| InChI | InChI=1S/C27H28N2O2/c30-27(28-19-11-4-12-20-28)24-25(21-13-5-1-6-14-21)29(23-17-9-3-10-18-23)31-26(24)22-15-7-2-8-16-22/h1-3,5-10,13-18,24-26H,4,11-12,19-20H2/t24-,25-,26+/m0/s1 |
| InChIKey | ODJURLBNKDQQMN-KKUQBAQOSA-N |
| Mol Weight | 412.53 g/mol |
| Molecular Formula | C27H28N2O2 |
| Exact Mass | 412.215078 g/mol |
| Enantiomer InChIKey | ODJURLBNKDQQMN-CYXNTTPDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
4-[(4-ethoxyphenyl)carbamoyl]-2,3-diphenyl-1,2-oxazolidine-5-carboxylic acid
(3'S,4S,4'R)-4-BENZYL-3-[(2',3'-DIPHENYLISOXAZOLIDIN-4'-YL)-CARBONYL]-1,3-OXAZOLIDIN-2-ONE
Ethyl (3R*,4R*,5R*)-5-(2-Bromophenyl)-3-(4-methoxyphenyl)-2-methylisoxazolidine-4-carboxylate
Ethyl (3R*,4S*,5S*)-5-(2-Bromophenyl)-3-(4-methoxyphenyl)-2-methylisoxazolidine-4-carboxylate
5-Menthoxy-4-(2,3-diphenylisozolidin-5-yl)furan-2(5H)-one
(2S,5S,6R)-1-benzoyl-2-tert-butyl-5-[(S)-hydroxy(phenyl)methyl]-3,6-dimethyl-1,3-diazinan-4-one
(Z)-methyl 3-[(2S*,3S*)-2,3-dihydro-6-oxo-1,2,4-triphenylpyrid-3-yl]propenoate
Isoxazolidine, 3-(2-methylphenyl)-2-phenyl-4-(phenylsulfonyl)-
1-(4-BROMOPHENYL)-3-[HYDROXY-(2-NITROPHENYL)-METHYL]-4-PHENYLAZETIDIN-2-ONE
(TRANS,TRANS)-N,N-PYRROLIDINYL-1-PHENYL-3-PYRROL-1-YLINDAN-2-CARBOXYAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| 1,3-Dipolar Cycloadditions VI [1].Structure and Conformation of Cycloadducts from Reactions of C-Aryl-N-phenylnitrones with Substituted Cinnamic Acid Amides | Monatshefte fuer Chemie/Chemical Monthly | 2000 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.